CN113403355B - 一种生物法生产l-5-甲基四氢叶酸的方法 - Google Patents
一种生物法生产l-5-甲基四氢叶酸的方法 Download PDFInfo
- Publication number
- CN113403355B CN113403355B CN202110672088.1A CN202110672088A CN113403355B CN 113403355 B CN113403355 B CN 113403355B CN 202110672088 A CN202110672088 A CN 202110672088A CN 113403355 B CN113403355 B CN 113403355B
- Authority
- CN
- China
- Prior art keywords
- mthf
- producing
- gene
- strain
- engineering bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 23
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 title claims abstract description 16
- 238000010170 biological method Methods 0.000 title claims abstract description 12
- ZNOVTXRBGFNYRX-STQMWFEESA-N (6S)-5-methyltetrahydrofolic acid Chemical compound C([C@@H]1N(C=2C(=O)N=C(N)NC=2NC1)C)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-STQMWFEESA-N 0.000 claims abstract description 85
- 241000894006 Bacteria Species 0.000 claims abstract description 57
- 238000000855 fermentation Methods 0.000 claims abstract description 24
- 230000004151 fermentation Effects 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 108010075604 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Proteins 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 230000006698 induction Effects 0.000 claims description 23
- 239000013612 plasmid Substances 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 239000013598 vector Substances 0.000 claims description 20
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 18
- 108010010685 Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 claims description 14
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 claims description 14
- 229960000723 ampicillin Drugs 0.000 claims description 14
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 14
- 229960005091 chloramphenicol Drugs 0.000 claims description 13
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 13
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 13
- 238000010367 cloning Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 241001656809 Clostridium autoethanogenum Species 0.000 claims description 8
- 101100281707 Methylorubrum extorquens (strain ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1) fhs gene Proteins 0.000 claims description 8
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 8
- 108010022394 Threonine synthase Proteins 0.000 claims description 8
- 101150064419 folA gene Proteins 0.000 claims description 8
- 101150051471 metF gene Proteins 0.000 claims description 8
- 239000012071 phase Substances 0.000 claims description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 8
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 6
- 239000012498 ultrapure water Substances 0.000 claims description 6
- WKZGKZQVLRQTCT-ABLWVSNPSA-N (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-formyloxy-5-oxopentanoic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(=O)OC=O)C(O)=O)C=C1 WKZGKZQVLRQTCT-ABLWVSNPSA-N 0.000 claims description 5
- 101100013238 Bacillus subtilis (strain 168) folB gene Proteins 0.000 claims description 5
- 108010080982 Formate-tetrahydrofolate ligase Proteins 0.000 claims description 5
- 101100171532 Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) hdrA gene Proteins 0.000 claims description 5
- 101100066441 Methylorubrum extorquens (strain ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1) fchA gene Proteins 0.000 claims description 5
- 101100178317 Methylorubrum extorquens (strain ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1) folK gene Proteins 0.000 claims description 5
- 239000004280 Sodium formate Substances 0.000 claims description 5
- 239000003957 anion exchange resin Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019254 sodium formate Nutrition 0.000 claims description 5
- 239000012137 tryptone Substances 0.000 claims description 5
- 101100131547 Methylorubrum extorquens (strain ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1) mtdA gene Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 4
- 235000011009 potassium phosphates Nutrition 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 2
- 102000002686 Formate-Tetrahydrofolate Ligase Human genes 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims 2
- 241000579120 Coliiformes Species 0.000 claims 1
- 241000589308 Methylobacterium extorquens Species 0.000 claims 1
- 241001052560 Thallis Species 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000007872 degassing Methods 0.000 claims 1
- 230000001335 demethylating effect Effects 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 abstract description 25
- 239000011578 levomefolic acid Substances 0.000 abstract description 14
- 235000007635 levomefolic acid Nutrition 0.000 abstract description 14
- 238000005457 optimization Methods 0.000 abstract description 14
- 230000037353 metabolic pathway Effects 0.000 abstract description 8
- 230000037361 pathway Effects 0.000 abstract description 4
- 230000015556 catabolic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 31
- 108090000790 Enzymes Proteins 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 12
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 125000003729 nucleotide group Chemical group 0.000 description 11
- 238000011529 RT qPCR Methods 0.000 description 9
- 101150042623 metH gene Proteins 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000005460 tetrahydrofolate Substances 0.000 description 8
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 7
- 241000432067 Methylobacterium extorquens AM1 Species 0.000 description 7
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 6
- 108090000364 Ligases Proteins 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 102000015654 Methylenetetrahydrofolate Dehydrogenase (NADP) Human genes 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 229930027917 kanamycin Natural products 0.000 description 5
- 229960000318 kanamycin Drugs 0.000 description 5
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
- 229930182823 kanamycin A Natural products 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 102000004419 dihydrofolate reductase Human genes 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- QYNUQALWYRSVHF-ABLWVSNPSA-N 5,10-methylenetetrahydrofolic acid Chemical compound C1N2C=3C(=O)NC(N)=NC=3NCC2CN1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-ABLWVSNPSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000672609 Escherichia coli BL21 Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 102000011848 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Human genes 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000006652 catabolic pathway Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- TUPQKZSGPDIJFD-MMFRDWCLSA-N (2s)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;formic acid Chemical compound OC=O.N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TUPQKZSGPDIJFD-MMFRDWCLSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002064 Anaemia macrocytic Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000445964 Clostridium autoethanogenum DSM 10061 Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 241000589323 Methylobacterium Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 101150009128 fhs gene Proteins 0.000 description 1
- 101150021184 fhs1 gene Proteins 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000011419 induction treatment Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 201000006437 macrocytic anemia Diseases 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- -1 strains Substances 0.000 description 1
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01003—Dihydrofolate reductase (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01005—Methylenetetrahydrofolate dehydrogenase (NADP+) (1.5.1.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01015—Methylenetetrahydrofolate dehydrogenase (NAD+) (1.5.1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/0102—Methylenetetrahydrofolate reductase [NAD(P)H] (1.5.1.20)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/07—Oxidoreductases acting on the CH-NH group of donors (1.5) with an iron-sulfur protein as acceptor (1.5.7)
- C12Y105/07001—Methylenetetrahydrofolate reductase (ferredoxin) (1.5.7.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04009—Methenyltetrahydrofolate cyclohydrolase (3.5.4.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/04—Other carbon-nitrogen ligases (6.3.4)
- C12Y603/04003—Formate--tetrahydrofolate ligase (6.3.4.3)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种生物法生产L‑5‑甲基四氢叶酸(L‑5‑MTHF)的方法,是在大肠杆菌中敲除了分解代谢途径中的甲硫氨酸合成酶基因(metH),并引入了一条新的产L‑5‑MTHF的代谢途径构建了产L‑5‑MTHF的工程菌BL21‑WL菌株或BL21(ΔmetH)‑C1T菌株,通过对所构建的工程菌产L‑5‑MTHF的发酵条件优化,所述工程菌最大细胞干重产量可达445.94μg·g‑1,比优化前提高了99.71%,达到出发菌株的10.0倍,换算为每升培养物的产量后可达1249.11μg,远大于目前报道中的以E.coli为宿主菌的L‑5‑MTHF产量(119.84μg·L‑1)。预示本发明方法及构建的工程菌具有极大的应用价值和市场前景。
Description
技术领域
本发明涉及一种生产L-5-甲基四氢叶酸(L-5-MTHF)的方法,尤其涉及一种利用构建大肠杆菌工程菌生物法生产L-5-MTHF的方法,属于生物技术领域。
背景技术
L-5-甲基四氢叶酸(L-5-MTHF),是维生素B9的生物活性形式,可直接被人体吸收参与体内的甲基化过程和DNA合成,对许多疾病都有一定的治疗作用,如巨红细胞贫血症、神经管缺陷和癌症等,在维持人体健康方面具有重要作用。作为叶酸类药物中唯一可以透过血脑屏障的物质,L-5-MTHF可以用来预防阿尔兹海默症,另外,人体中亚甲基四氢叶酸还原酶基因突变会影响体内L-5-MTHF的合成,也会引发人体的一系列疾病,因此,对于亚甲基四氢叶酸还原酶基因突变的人群来说,直接服用L-5-MTHF类药物是十分必要的。欧盟委员会于2014年3月19日决定将L-5-MTHF作为一种新型食品添加剂,增加了L-5-MTHF的市场需求量,这迫使需不断的更新技术以获得更大量的L-5-MTHF。
在已有的文献报道中,大部分5-MTHF都是经化学法合成的,以叶酸为原料,先还原为四氢叶酸,后经甲基化和进一步还原生成5-MTHF。但化学合成需要大量的强化学还原剂,具有一定的危险性,且合成的5-MTHF是外消旋混合物,需要通过手性拆分获得具有生物活性的L-5-MTHF。此外,化学法合成5-MTHF产率小,纯度低,污染环境,不利于人体健康。
经检索,有关对Escherichia coli进行代谢改造,在其细胞中构建新的合成L-5-MTHF代谢途径,且阻断L-5-MTHF的分解代谢途径,并进一步通过优化发酵条件的生物法合成L-5-MTHF的方法还未见报道。
发明内容
针对现有技术的不足,本发明要解决的问题是提供一种利用大肠杆菌工程菌生物法生产L-5-甲基四氢叶酸(L-5-MTHF)的方法。
本发明所述的生物法生产L-5-MTHF的方法,步骤是:
(1)构建产L-5-MTHF的工程菌:
a.以Escherichia.coli BL21(DE3)基因组为模板扩增SEQ ID NO.3所示的二氢叶酸还原酶基因folA以及SEQ ID NO.4所示的亚甲基四氢叶酸还原酶基因metF,将folA基因和metF基因克隆到pACYCDuet-1载体的两个多克隆位点上,构建重组质粒,命名为pACYCDuet-metF-folA;以Clostridium autoethanogenum基因组为模板扩增SEQ ID NO.5所示的甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因fhs-fchA-folD,将fhs-fchA-folD基因克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-WL;以Methylobacterium extorquens AM1基因组作为模板扩增SEQ IDNO.6所示的甲酸四氢叶酸连接酶基因ftfL以及SEQ ID NO.7所示的甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因fchA-mtdA,将ftfL、fchA和mtdA克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-C1T;
b.将质粒pACYCDuet-metF-folA和pETDuet-WL共同转化到E.coli BL21(DE3)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养,阳性菌落菌株即为产L-5-MTHF的工程菌,命名为BL21-WL;将质粒pACYCDuet-metF-folA和pETDuet-C1T共同转化到敲除甲硫氨酸合成酶基因(metH)的E.coli BL21(ΔmetH)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养,阳性菌落菌株即为产L-5-MTHF的工程菌,命名为BL21(ΔmetH)-C1T;
(2)产L-5-MTHF的工程菌发酵:
将产L-5-MTHF的工程菌BL21-WL菌株或BL21(ΔmetH)-C1T菌株以体积比1~5%的接种量接种到含有氨苄青霉素和氯霉素的发酵培养基中,在37±1℃和180~220rpm转速条件下培养2~4小时至OD600nm为0.6~1.0,获得菌液;向制得的菌液中加入终浓度为0.4~0.8mM的IPTG,在20~37℃、100~120rpm转速下诱导8~16小时,然后将培养液离心收集菌体,即获得含L-5-MTHF的工程菌细胞;
其中,上述发酵培养基的配方及组分终浓度是:胰蛋白胨10~15g·L-1,酵母粉20~30g·L-1,甘油2~5ml·L-1,叶酸0.01~0.4g·L-1,甲酸钠0.1~4.0g·L-1,KH2PO4 2~4g·L-1,K2HPO4 12~14g·L-1;氨苄青霉素终浓度为50μg·ml-1,氯霉素的终浓度为25μg·ml-1;
(3)破碎工程菌细胞,释放出L-5-MTHF:
将离心后获得的工程菌细胞在厌氧箱中用含0.1%的抗坏血酸和含0.1%巯基乙醇的50mM pH 7.2的经煮沸后脱气厌氧处理的Tris-HCl溶液重悬,密封在厌氧小瓶中,100℃水浴煮沸10min破碎细胞,即得含L-5-MTHF的细胞破碎液,立即将其冰浴,并于15,000rpm,4℃离心15min后收集上清,再加入新鲜小鼠血清至100μl·ml-1,37℃反应3h,煮沸5min终止反应,离心取上清,用0.22μm的醋酸纤维素滤膜过滤,滤液装入液相小瓶;
(4)使用201×7强碱性苯乙烯系阴离子交换树脂纯化L-5-MTHF,并使用高效液相色谱(HPLC)对L-5-MTHF产量进行测定:
其中L-5-MTHF的纯化方法是:用1M的NaOH和1M的HCl处理强碱性苯乙烯系阴离子交换树脂2次,超纯水洗至中性,再用1M的NaOH浸泡树脂24h,将其转变为OH型,用超纯水洗至中性,用50mM pH 7.2的Tris-HCl缓冲液平衡柱子至流出液与缓冲液pH值相同,将步骤(3)液相小瓶中的滤液样品在避光条件下上样,用0.1M pH 7.2的NaCl洗脱,紫外检测器在290nm下检测并收集洗脱液;
其中HPLC对L-5-MTHF测定的方法是:荧光检测器Ex=290nm,Em=356nm,以体积比为93:7的33mM pH 3.0磷酸钾和乙腈为流动相,上样量20μl,走样时间30min,柱温箱温度为30℃,保留时间为19.3±0.1min。
上述33mM磷酸钾(pH 3.0)的配制:先配制33mM K2HPO4,随后用33mM的H3PO4调节pH至3.0。
标准品的配制:准确称取20mg 5-MTHF标准品粉末于流动相中,用1M NaOH溶液调节pH值至完全溶解,定容至100ml,可得浓度为2mg·ml-1的5-MTHF溶液,将该溶液进行梯度稀释,取0.5、1.0、2.0、4.0、5.0μg·ml-1的5-MTHF标准品溶液做标准曲线,标准曲线方程为y=316802x-9684.3(R2=0.9999),根据峰面积计算每株工程菌的L-5-MTHF的产量。
上述生物法生产L-5-MTHF的方法中:步骤(2)所述工程菌BL21-WL菌株或BL21(ΔmetH)-C1T菌株的发酵条件优选是在37℃和220rpm转速条件下培养2~3小时至OD600nm为0.6~0.8,并向菌液中加入终浓度为0.6~0.8mM的IPTG,在20~25℃、100~110rpm转速下诱导12~16小时。
上述生物法生产L-5-MTHF的方法中:步骤(2)所述发酵培养基的配方及组分终浓度优选是:胰蛋白胨12g·L-1,酵母粉24g·L-1,甘油4ml·L-1,叶酸0.13g·L-1,甲酸钠1.3g·L-1,KH2PO4 2.3g·L-1,K2HPO4 12.5g·L-1。
本发明公开了一种生物法生产L-5-MTHF的方法,并成功构建了产L-5-MTHF的大肠杆菌工程菌株,其创新点是在大肠杆菌中构建了一条新的产L-5-MTHF途径,该途径含有来源于E.coli BL21(DE3)的二氢叶酸还原酶和亚甲基四氢叶酸还原酶基因及外源一碳代谢途径的甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因,并且对E.coli BL21(DE3)中L-5-MTHF分解代谢途径的甲硫氨酸合成酶基因进行了敲除;所述重组大肠杆菌是将二氢叶酸还原酶和亚甲基四氢叶酸还原酶基因连接入pACYCDuet-1载体,将外源一碳代谢途径的相关基因连接入pETDuet-1载体,并将制得的重组质粒共转入E.coli BL21(DE3)和E.coli BL21(ΔmetH)中获得。本发明方法对于L-5-MTHF的绿色生产具有重要价值。它的应用在于用生物法合成L-5-MTHF专一性强,纯度高,不需要繁琐的化学合成步骤,绿色环保,节省了大量的时间,节约了成本。
实验证实:本发明在E.coli BL21(DE3)产L-5-MTHF的代谢途径的基础上引入了一条新的产L-5-MTHF的途径(见图1),使L-5-MTHF的产量显著提高。通过qRT-PCR检测到在加入IPTG诱导后,工程菌的外源基因转录水平均得到了较大幅度的提升(见图2);通过HPLC成功检测到了目的产物L-5-MTHF,其保留时间在19.3±0.1min(见图3),并通过LC-MS验证了L-5-MTHF的正确性(见图4);通过对所构建的工程菌产L-5-MTHF的发酵条件进行初步优化后,发现工程菌最大细胞干重产量可达445.94μg·g-1(见图6、图7),比优化前提高了99.71%,达到出发菌株的10.0倍,换算为每升培养物的产量后可达1249.11μg,远大于目前报道中的以E.coli为宿主菌的L-5-MTHF产量(119.84μg·L-1),对Bacillus subtilis进行代谢工程改造后优化发酵条件所获得的L-5-MTHF的最高产量为1.78mg·L-1,是当前报道中的最高产量,而本发明所构建的工程菌的产量仅在初步优化发酵条件后就已经很接近目前的最高产量,具有极大的应用价值和市场前景。
附图说明
图1:大肠杆菌合成L-5-MTHF新途径的构建
其中,方框中的物质为需要补加的外源物质,实线箭头为大肠杆菌自身的代谢途径,虚线箭头为引入的外源代谢途径。DHFR:二氢叶酸还原酶;MTHFR:亚甲基四氢叶酸还原酶;MTRR:甲硫氨酸合成酶。
图2:BL21-WL(A)和BL21(ΔmetH)-C1T(B)工程菌中外源基因转录水平变化的qRT-PCR分析结果。
图3:5-MTHF标准品(A)及工程菌中L-5-MTHF(B)色谱图。
图4:BL21-WL工程菌中L-5-MTHF的LC-MS分析。
其中L-5-MTHF放大显示在图A插图中;B为BL21-WL工程菌的L-5-MTHF质谱图。L-5-MTHF m/z理论值为460.1939。
图5:5-MTHF标准曲线。
图6:BL21-WL工程菌发酵条件初步优化。
图7:BL21(ΔmetH)-C1T工程菌发酵条件初步优化。
上述图6和图7中,a为在不同诱导时间下的产量变化情况;b为在最适诱导时间下,在不同诱导温度下的产量变化情况;c为最适诱导时间和温度下,添加不同终浓度的IPTG对产量的影响;d为在不同OD600nm值下添加IPTG对产量的影响,其余条件均最适。
具体实施方式
下面结合具体附图和实施例对本发明内容进行详细说明。如下所述例子仅是本发明的较佳实施方式而已,应该说明的是,下述说明仅仅是为了解释本发明,并非对本发明作任何形式上的限制,凡是依据本发明的技术实质对实施方式所做的任何简单修改,等同变化与修饰,均属于本发明技术方案的范围内。
本发明中所用菌株、材料及来源说明:
E.coli DH5α和E.coli BL21(DE3)细胞购买自Lucigen公司,Clostridiumautoethanogenum购买自德国菌种保藏中心(DSM 10061),Methylobacterium extorquensAM1由购买自美国模式菌种收集中心(ATCC 14718)。
E.coli BL21(ΔmetH)菌株为E.coli BL21(DE3)敲除metH基因的工程菌株,其制备方法是:
以E.coli BL21(DE3)为出发菌株,根据甲硫氨酸合成酶基因metH(SEQ ID NO.1所示的核苷酸序列)设计引物。以metH_P1:TGGAATTGGGTAACCCGGCTTGTTGCGC、metH_P2:AAGCAGCTCCAGCCTACACTTGTTCCACTTTGCTGCTCAC为引物,以E.coli BL21(DE3)基因组为模板,PCR扩增metH基因上同源臂片段;以metH_P3:GGACCATGGCTAATTCCCATGCACCGAATCTGGGGTATGAC、metH_P4:TGCTCTGTACCAGTGCGGTAACGCCG为引物,E.coli BL21(DE3)基因组为模板,PCR扩增metH基因下同源臂片段P2;根据如SEQ ID NO.2所示的带有FRT位点的卡那霉素抗性基因核苷酸序列设计引物,metH_P5:GTGAGCAGCAAAGTGGAACAAGTGTAGGCTGGAGCTGCTT和metH_P6:GTCATACCCCAGATTCGGTGCATGGGAATTAGCCATGGTCC,pKD4质粒为模板,PCR扩增带有FRT位点的卡那霉素抗性基因片段P3;切胶回收P1、P2、P3片段,Over lapping PCR连接P1、P2和P3片段,制备打靶片段。将打靶片段电转入含有pTKRed质粒的E.coli Bl21(DE3)中,将metH基因通过同源重组替换为带有FRT位点的卡那霉素抗性基因片段,并在42℃下过夜培养,去除掉pTKRed质粒。最后将可以热诱导FLP(flip-out)重组酶的温度敏感质粒pCP20电转入去除了pTKRed质粒的工程菌中,以消除卡那霉素抗性基因片段,并在42℃下过夜培养,去除掉pCP20质粒,最终得到敲除metH基因的菌株,命名为E.coli BL21(ΔmetH)。
质粒小提试剂盒、DNA纯化回收试剂盒、细菌基因组DNA提取试剂盒购自天根生化科技(北京)有限公司。Top Green qPCR Supermix、Easypure RNA Kit和高保真FastPfuDNA聚合酶购自北京全式金生物技术有限公司。5×All-In-One MasterMix和AccuRT Genomic DNA Removal kit购自爱必梦生物科技有限公司。pACYCDuet-1和pETDuet-1载体购自Novagen公司。pTKRed、pKD4和pCP20质粒购买自BioVector质粒载体菌种细胞基因保藏中心。限制性内切酶、T4 DNA连接酶购自Thermo公司。HPLC所用色谱柱为ChromCore120C18柱,购自纳普分析技术有限公司。
下述实施例中,所使用的材料、菌株、试剂等,如无特殊说明,均从商业途径得到。
实施例1:产L-5-MTHF的工程菌的构建
取Clostridiumautoethanogenum和Methylobacterium extorquens AM1细胞,按照细菌基因组DNA提取试剂盒推荐方法,从细胞中分别提取其基因组DNA。
根据已知的E.coli BL21(DE3)基因组中如核苷酸序列SEQ ID NO.3所示的二氢叶酸还原酶基因(folA)序列设计引物folA_F:GGAATTCCATATGATCAGTCTGATTGCGGC和folA_R:CCGCTCGAGTTACCGCCGCTC,以E.coli BL21(DE3)基因组为模板扩增folA基因,PCR循环参数为95℃5min;(95℃30s,56℃30s,72℃15s);72℃10min,30个循环。
根据已知的E.coli BL21(DE3)基因组中如核苷酸序列SEQ ID NO.4所示的亚甲基四氢叶酸还原酶基因(metF)序列设计引物metF_F:CATGCCATGGGCATGAGCTTTTTTCACG和metF_R:CCCAAGCTTTTATAAACCAGGTCGAACCC,以E.coli BL21(DE3)基因组为模板扩增metF基因序列。PCR循环参数为95℃5min;[95℃30s,56℃30s,72℃27s];72℃10min,30个循环。
将folA基因和metF基因克隆到pACYCDuet-1载体的两个多克隆位点上,构建重组质粒,命名为pACYCDuet-metF-folA。
根据已知的C.autoethanogenum基因组中如核苷酸序列SEQ ID NO.5所示的甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因(fhs-fchA-folD)序列设计引物CA1616.1618_F:GGAATTCCATATGACTTATAAATCAGAC和CA1616.1618_R:CCCTCGAGTTATAGGTTATTTTGTAAC,以C.autoethanogenum DSM 10061基因组为模板扩增fhs-fchA-folD序列。PCR循环参数为95℃10min;[95℃30s,48℃30s,72℃48s];72℃10min,30个循环。
将fhs-fchA-folD基因克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-WL。
将C.autoethanogenum中的甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因(fhs、fchA和folD)替换为来源于M.extorquens AM1的功能相同的酶的基因ftfL、fchA和mtdA。
根据已知的M.extorquens AM1基因组中如SEQ ID NO.6所示的甲酸四氢叶酸连接酶基因(ftfL)序列设计引物ftfL_F:CGCGGATCCATGCCCTCAGATATCGAGATC和ftfL_R:CCCAAGCTTCTAGAACAGCCCGTCGATC,以M.extorquens AM1基因组作为模板扩增ftf_L基因;根据已知的M.extorquens AM1基因组中如SEQ ID NO.7所示的甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因(fchA-mtdA)序列设计引物mf_F:CGCCATATGTCCAAGAAGCTGCTCTTCCAG和mf_R:CGGGGTACCTCAGTTTACCTTGGACTTCACCGTC,以M.extorquens AM1基因组作为模板扩增mtdA-fchA序列。两段基因的PCR的循环参数均为:95℃10min;[95℃30s,65℃30s,72℃45s];72℃10min,30个循环。
将甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因(ftfL、fchA和mtdA)克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-C1T。
以上所有的PCR反应体系如下:
以上所有PCR产物经琼脂糖凝胶电泳初步确认正确后,用DNA纯化回收试剂盒纯化。将纯化的PCR产物与载体分别在37℃酶切30min,酶切体系如下:
以上所有连接反应体系如下:
25℃反应1h,所得连接产物(重组载体)分别在冰上加入到E.coli DH5α感受态细胞中,冰浴30分钟,37℃热击5min,冰浴5min,加入500μl无抗生素的LB液体培养基,37℃震荡培养1h,分别在含氯霉素和氨苄青霉素抗性的LB固体平板上培养12h,挑取单菌落,双酶切验证和测序筛选阳性克隆,分别命名为DH5α-pACYCDuet-metF-folA、DH5α-pETDuet-WL和DH5α-pETDuet-C1T,保存甘油管。
将DH5α-pACYCDuet-metF-folA、DH5α-pETDuet-WL和DH5α-pETDuet-C1T在5ml LB摇管中过夜培养后,分别提取质粒pACYCDuet-metF-folA、pETDuet-WL和pETDuet-C1T,将质粒pACYCDuet-metF-folA和pETDuet-WL共同转化到E.coli BL21(DE3)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养12h,挑取单菌落,PCR验证目的基因片段,挑选阳性菌落,所得工程菌株即为产L-5-MTHF的工程菌,命名为BL21-WL;将质粒pACYCDuet-metF-folA和pETDuet-C1T共同转化到敲除甲硫氨酸合成酶基因(metH)的E.coli BL21(ΔmetH)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养12h,挑取单菌落,PCR验证目的基因片段,挑选阳性菌落,所得工程菌株即为产L-5-MTHF的工程菌,命名为BL21(ΔmetH)-C1T。
上述重组质粒共同转入宿主菌的条件为:取相同质量的两种重组质粒共10μl,加入到100μl感受态细胞中,冰浴30min,42℃热激90s后立即置于冰上5min,加入500μl无抗生素的LB液体培养基,37℃孵育1h后取50μl菌液涂布在含有1‰氨苄青霉素和氯霉素的固体LB平板上,37℃过夜培养,挑取单菌落。
新构建的产L-5-MTHF的代谢途径见图1。
实施例2:工程菌株的外源基因转录水平分析
将实施例1中BL21-WL和BL21(ΔmetH)-C1T工程菌在培养基中培养至OD600nm值为0.8时,取1ml菌液,作为诱导前的样品。然后加入终浓度为0.8mM的IPTG诱导12h,取1ml菌液,并用无菌生理盐水稀释至OD600nm值为0.8,作为诱导处理后的菌液。收集到的细胞用Easypure RNA Kit提取RNA,再用AccuRT Genomic DNA Removal kit和5×All-In-OneMasterMix反转录生成cDNA(25℃10min;42℃15min;85℃5min),将cDNA稀释到相同浓度后作为qPCR分析的模板。qPCR以Top Green qPCR Supermix作为染料,使用LightCycler 480进行反应。
以16s rRNA基因的表达水平作为内参,每个样本做三组平行,并对所有样本的Ct值进行计算,用2-ΔΔCt法计算基因表达的相对倍数变化,qRT-PCR反应所需引物核苷酸序列如下所示。
qRT-PCR反应体系如下:
qRT-PCR反应程序:
测定结果表明,BL21-WL和BL21(ΔmetH)-C1T工程菌中转入的外源基因在诱导后的转录水平均大幅度提高。见图2。
实施例3:工程菌中L-5-MTHF的产量计算方法及LC-MS分析
(1)实施例1中所得BL21-WL或BL21(ΔmetH)-C1T工程菌细胞的破碎方法是:将离心后获得的工程菌细胞在厌氧箱中用含0.1%的抗坏血酸和含0.1%巯基乙醇的50mMTris-HCl(pH 7.2)重悬至相同体积,用橡胶塞密封在厌氧小瓶中,100℃水浴煮沸10min破碎细胞,即得含L-5-MTHF的细胞破碎液。随即立即冰浴,15,000rpm,4℃离心15min后收集上清,加入新鲜小鼠血清(100μl·ml-1),37℃反应3h,煮沸5min终止反应,离心取上清,用0.22μm的醋酸纤维素滤膜过滤,滤液装入液相小瓶。
上述步骤中50mM Tris-HCl(pH 7.2)溶液煮沸后脱气厌氧处理。
(2)L-5-MTHF的纯化方法:用1M的NaOH和1M的HCl处理强碱性苯乙烯系阴离子交换树脂2次,超纯水洗至中性,再用1M的NaOH浸泡树脂24h,将其转变为OH型,用超纯水洗至中性,用50mM的Tris-HCl(pH 7.2)缓冲液平衡柱子至流出液与缓冲液pH值相同,将步骤(3)中处理好的样品在避光条件下上样,用0.1M的NaCl(pH 7.2)洗脱,紫外检测器在290nm下检测并收集洗脱液。
(3)HPLC检测L-5-MTHF产量的方法是:荧光检测器Ex=290nm,Em=356nm,以33mM磷酸钾(pH 3.0)和乙腈(93:7,v/v)为流动相,上样量20μl,走样时间30min,柱温箱温度为30℃,保留时间为19.3±0.1min左右。配制5-MTHF标准品:准确称取20mg 5-MTHF标准品粉末于流动相中,用1M NaOH溶液调节pH值至完全溶解,定容至100ml,可得浓度为0.2mg/ml的5-MTHF溶液,将该溶液进行梯度稀释,取0.5、1.0、2.0、4.0、5.0μg/ml的5-MTHF标准品溶液做标准曲线,标准曲线方程为y=316802x-9684.3(R2=0.9999),根据峰面积计算每株工程菌的L-5-MTHF的产量。
(4)LC-MS分析目的产物的正确性:取处理好的菌体细胞破碎液经0.22μm滤膜过滤后装入液相小瓶,液相色谱质谱联用(LC-MS)的检测程序参照HPLC程序,将流动相A相的33mM硫酸钾溶液换为8mM的甲酸溶液,使用ChromCore 120C18柱分析,具体程序如下:紫外检测器检测波长290nm,跑样时间30min,流动相为8mM甲酸—乙腈(90:10),进样量10μL,流速为0.5ml·min-1。MS分析由otofControl软件(Bruker Daltonics)在以下条件下进行:ESI-阳性模式扫描,增强二次模式校准,雾化器气体氮气1bar,干燥气体氮气8L·min-1,探针温度180℃,全扫描质量范围为50至700m/z。数据由DataAnalysis软件(BrukerDaltonics)分析。
结果表明,在BL21-WL或BL21(ΔmetH)-C1T工程菌细胞破碎中检测到了目的产物L-5-MTHF,证明了本发明所需目标产物的正确性。见图3、图4、图5。
实施例4:BL21-WL和BL21(ΔmetH)-C1T工程菌中的关键酶亚甲基四氢叶酸脱氢酶和亚甲基四氢叶酸还原酶酶活的测定
工程菌粗酶液的制备:按最适诱导条件诱导获得1L的BL21-WL或BL21(ΔmetH)-C1T工程菌液,4℃,6,000rpm离心10min后弃上清,用50mM Tris-HCl(pH 7.4)重悬菌体,离心弃上清,以彻底除去培养基,再次离心收集菌体并重悬到破碎杯中,用超声破碎仪破碎菌体,总共破碎40min(破碎5s,间歇6s,破碎功率为50%),将细胞破碎液装入超速离心管中4℃,20,000g,离心15min,取上清进行酶活的测定。
蛋白质浓度测定:以牛血清白蛋白为标准品,参照Bradford法进行测定细胞破碎液的蛋白浓度。
粗酶中亚甲基四氢叶酸还原酶比活的测定:在用橡胶塞密封的1cm石英厌氧比色皿中进行反应,厌氧比色皿中充入N2,以50mM Tris-HCl(含2mM DTT,pH 7.4)作为反应缓冲液,在恒定37℃环境中,利用紫外分光光度计监测反应的进行。
反应体系如下:
以粗酶起始反应,可以发现体系吸光值逐渐上升,最后趋于平缓,通过吸光值上升的速度再根据朗伯比尔定律计算亚甲基四氢叶酸还原酶的比活,计算公式如下:
V总是总反应体系的体积,单位ml;
V酶是加入粗酶液的体积,单位ml;
N是粗酶液的浓度,单位mg·ml-1;
L是比色皿的光程,单位cm;
ε是NADH在340nm的摩尔消光系数,为ε=6.2mM-1cm-1。
1个酶活力单位(U)定义为每分钟还原1μmol亚甲基四氢叶酸所需要的酶量。
粗酶中亚甲基四氢叶酸脱氢酶比活的测定:在用橡胶塞密封的1cm石英厌氧比色皿中进行反应,厌氧比色皿中充入N2,以100mM的MOPS-KOH(含2mM DTT,pH 6.5)作为反应缓冲液,反应体系如下:
加入粗酶起始反应,可以发现体系吸光值逐渐上升,最后趋于平缓,通过吸光值上升的速度再根据上述朗伯比尔定律计算亚甲基四氢叶酸脱氢酶的比活,其中ε为30.5mM- 1cm-1[NAD(P)Hε=5.6mM-1cm-1,亚甲基四氢叶酸ε=24.9mM-1cm-1]。
1个酶活力单位(U)定义为每分钟还原1μmol亚甲基四氢叶酸和NAD(P)H所需要的酶量。
结果显示:BL21-WL和BL21(ΔmetH)-C1T工程菌中亚甲基四氢叶酸还原酶的比酶活分别为0.114±0.005和0.177±0.083,相比于E.coli BL21(DE3)的0.073±0.003,分别提高了0.36和0.86倍;亚甲基四氢叶酸脱氢酶的比酶活为0.047±0.0007和0.033±0.008,相比于E.coli BL21(DE3)的0.003±0.0003,提高了14.67和10.00倍。
实施例5:工程菌BL21-WL产L-5-MTHF的发酵条件初步优化
(1)实施例1构建的BL21-WL工程菌菌株的初始发酵条件为:将BL21-WL工程菌以体积比1%的接种量接种到含有氨苄青霉素和氯霉素的发酵培养基中,37℃培养至OD600nm为0.8时加入0.8mM IPTG,25℃诱导12h;
其中,上述发酵培养基的配方及组分终浓度是:Tryptone 12g·L-1,Yeastextract 24g·L-1,Glycerol 4ml·L-1,KH2PO4 2.3g·L-1,K2HPO4 12.5g·L-1,叶酸0.13g·L-1,甲酸钠1.3g·L-1。
上述抗生素为终浓度为25μg·ml-1的氯霉素和终浓度为50μg·ml-1的氨苄青霉素。
(2)对BL21-WL工程菌的诱导时间进行优化,诱导时间分别为4h、8h、12h、16h、20h,确定最适诱导时间为16h。
(3)在BL21-WL最适诱导时间下,对工程菌的诱导温度进行优化,分别在20℃、25℃、30℃、37℃下诱导,确定最适诱导温度为25℃。
(4)在最适诱导时间及温度下加入终浓度为0.4mM、0.6mM、0.8mM、1.0mM的IPTG进行最适IPTG终浓度筛选,确定L-5-MTHF产量最大时的IPTG终浓度为0.6mM。
(5)在37℃,220rpm下培养菌体长至OD600nm值分别为0.4、0.6、0.8、1.0时加入最适浓度的IPTG(0.6mM),其它条件均保持最适,筛选出加入IPTG的最适时间为OD600nm值为0.8。
结果显示:BL21-WL工程菌在发酵培养基中37℃,220rpm培养至OD600nm值为0.8时添加0.6mM的IPTG,25℃,110rpm诱导16h,产量可达445.94μg·g-1DCW,比优化前(223.29μg·g-1DCW)提高了99.71%,达到出发菌株E.coli BL21(DE3)(44.62μg·g-1DCW)的10.0倍,见图6。
实施例6:工程菌BL21(ΔmetH)-C1T产L-5-MTHF的发酵条件初步优化
将实施例1构建的BL21(ΔmetH)-C1T工程菌菌株按实施例5中的方法进行发酵条件的初步优化。诱导时间选4h、8h、12h和16h进行优化,确定最适诱导时间为12h;诱导温度选20℃、25℃、30℃和37℃进行优化,确定适诱导温度为25℃;加入IPTG的终浓度选0.4mM、0.6mM、0.8mM和1.0mM进行优化,确定最适IPTG终浓度为0.6mM;加入IPTG时的OD600nm值选0.4、0.6、0.8和1.0进行优化,确定最适加入IPTG的OD600nm值为0.8。
结果显示:BL21(ΔmetH)-C1T工程菌在发酵培养基中37℃,220rpm培养至OD600nm值为0.8时添加0.6mM的IPTG,25℃,110rpm诱导12h,细胞干重产量可达380.01μg·g-1,比优化前(157.26μg·g-1DCW)提高了141.64%,达到出发菌株E.coli BL21(DE3)的8.5倍,见图7。
序列表
<110>山东大学
<120>一种生物法生产L-5-甲基四氢叶酸的方法
<141> 2021-06-11
<160>7
<210> 1
<211>3684
<212> DNA
<213> Escherichia coli BL21(DE3)
<221> 甲硫氨酸合成酶基因(metH)的核苷酸序列
<222>(1)…(3684)
<400> 1
gtgagcagca aagtggaaca actgcgtgcg cagttaaatg aacgtattct ggtgctggac 60
ggcggtatgg gcaccatgat ccagagttat cgactgaacg aagccgattt tcgtggtgaa 120
cgctttgccg actggccatg cgacctcaaa ggcaacaacg acctgctggt actcagtaaa 180
ccggaagtga tcgccgctat ccacaacgcc tactttgaag cgggcgcgga tatcatcgaa 240
accaacacct tcaactccac gaccattgcg atggcggatt accagatgga atccctgtcg 300
gcggaaatca actttgcggc ggcgaaactg gcgcgagctt gtgctgacga gtggaccgcg 360
cgcacgccag agaaaccgcg ctacgttgcc ggtgttctcg gcccgaccaa ccgcacggcg 420
tctatttctc cggacgtcaa cgatccggca tttcgtaata tcacttttga cgggctggtg 480
gcggcttatc gagagtccac caaagcgctg gtggaaggtg gcgcggatct gatcctgatt 540
gaaaccgttt tcgacaccct taacgccaaa gcggcggtat ttgcggtgaa aacggagttt 600
gaagcgctgg gcgttgagct gccgattatg atctccggca ccatcaccga cgcctccggg 660
cgcacgctct ccgggcagac caccgaagca ttttacaact cattgcgcca cgccgaagct 720
ctgacctttg gcctgaactg tgcgctgggg cccgatgaac tgcgccagta cgtgcaggag 780
ctgtcacgga ttgcggaatg ctacgtcacc gcgcacccga acgccgggct acccaacgcc 840
tttggtgagt acgatctcga cgccgacacg atggcaaaac agatacgtga atgggcgcaa 900
gcgggttttc tcaatatcgt cggcggctgc tgtggcacca cgccacaaca tattgcagcg 960
atgagtcgtg cagtagaagg attagcgccg cgcaaactgc cggaaattcc cgtagcctgc 1020
cgtttgtccg gcctggagcc gctgaacatt ggcgaagata gcctgtttgt gaacgtgggt 1080
gaacgcacca acgtcaccgg ttccgctaag ttcaagcgcc tgatcaaaga agagaaatac 1140
agcgaggcgc tggatgtcgc gcgtcaacag gtggaaaacg gcgcgcagat tatcgatatc 1200
aacatggatg aagggatgct cgatgccgaa gcggcgatgg tgcgttttct caatctgatt 1260
gccggtgaac cggatatcgc tcgcgtgccg attatgatcg actcctcaaa atgggacgtc 1320
attgaaaaag gtctgaagtg tatccagggc aaaggcattg ttaactctat ctcgatgaaa 1380
gagggcgtcg atgcctttat ccatcacgcg aaattgttgc gtcgctacgg tgcggcagtg 1440
gtggtaatgg cctttgacga acagggacag gccgatactc gcgcacggaa aatcgagatt 1500
tgccgtcggg cgtacaaaat cctcaccgaa gaggttggct tcccgccaga agatatcatc 1560
ttcgacccaa acatcttcgc ggtcgcaact ggcattgaag agcacaacaa ctacgcgcag 1620
gactttatcg gcgcgtgtga agacatcaaa cgcgaactgc cgcacgcgct gatttccggc 1680
ggcgtatcta acgtttcttt ctcgttccgt ggcaacgatc cggtgcgcga agccattcac 1740
gcagtgttcc tctactacgc tattcgcaat ggcatggata tggggatcgt caacgccggg 1800
caactggcga tttacgacga cctacccgct gaactgcgcg acgcggtgga agatgtgatt 1860
cttaatcgtc gcgacgatgg caccgagcgt ttactggagc ttgccgagaa atatcgcggc 1920
agcaaaaccg acgacaccgc caacgcccag caggcggagt ggcgctcgtg ggaagtgaat 1980
aaacgtctgg aatactcgct ggtcaaaggc attaccgagt ttatcgagca ggataccgaa 2040
gaagcccgcc agcaggctac gcgcccgatt gaagtgattg aaggcccgtt gatggacggc 2100
atgaatgtgg tcggcgacct gtttggcgaa gggaaaatgt tcctgccaca ggtggtcaaa 2160
tcggcgcgcg tcatgaaaca ggcggtggcc tacctcgaac cgtttattga agccagcaaa 2220
gagcagggca aaaccaacgg caagatggtg atcgccaccg tgaagggcga cgtccacgac 2280
atcggtaaaa atatcgttgg tgtggtgctg caatgtaaca actacgaaat tgtcgatctc 2340
ggcgttatgg tgcctgcgga aaaaattctc cgtaccgcta aagaagtgaa tgctgatctg 2400
attggccttt cggggcttat cacgccgtcg ctggacgaga tggttaacgt ggcgaaagag 2460
atggagcgtc agggcttcac tattccgtta ctgattggcg gcgcgacgac ctcaaaagcg 2520
cacacggcgg tgaaaatcga gcagaactac agcggcccga cggtgtatgt gcagaatgcc 2580
tcgcgtaccg ttggtgtggt ggcggcgctg ctttccgata cccagcgtga tgattttgtc 2640
gctcgtaccc gcaaggagta cgaaaccgta cgtattcagc acgggcgcaa gaaaccgcgc 2700
acaccaccgg tcacgctgga agcggcgcgc gataacgatt tcgcttttga ctggcaggct 2760
tacacgccgc cggtggcgca ccgtctcggc gtgcaggaag tcgaagccag catcgaaacg 2820
ctgcgtaatt acatcgactg gacaccgttc tttatgacct ggtcgctggc cgggaagtat 2880
ccgcgcattc tggaagatga agtggtgggc gttgaggcgc agcggctgtt taaagacgcc 2940
aacgacatgc tggataaatt aagcgccgag aaaacgctga atccgcgtgg cgtggtgggc 3000
ctgttcccgg caaaccgtgt gggcgatgac attgaaatct accgtgacga aacgcgtacc 3060
catgtgatca acgtcagcca ccatctgcgt caacagaccg aaaaaacagg cttcgctaac 3120
tactgtctcg ctgacttcgt tgcgccgaag ctttctggta aagcagatta catcggcgca 3180
tttgccgtga ctggcgggct ggaagaggac gcactggctg atgcctttga agcgcagcac 3240
gatgattaca acaaaatcat ggtgaaagcg cttgccgacc gtttagccga agcctttgcg 3300
gagtatctcc atgagcgtgt gcgtaaagtc tactggggct atgcgccgaa cgagaacctc 3360
agcaacgaag agctgatccg cgaaaactac cagggcatcc gtccggcacc gggctatccg 3420
gcctgcccgg aacatacgga aaaagccacc atctgggagc tgctggaagt ggaaaaacac 3480
actggcatga aactcacaga atctttcgcc atgtggcccg gtgcatcggt ttcgggttgg 3540
tacttcagcc acccggacag caagtactac gctgtagcac aaattcagcg cgatcaggtt 3600
gaagattatg cccgccgtaa aggtatgagc gttaccgaag ttgagcgctg gctggcaccg 3660
aatctggggt atgacgcgga ctga 3684
<210> 2
<211>3267
<212> DNA
<213> pKD4
<221> 带有FRT位点的卡那霉素抗性基因的核苷酸序列
<222>(1)…(3267)
<400> 2
gaagttccta tactttctag agaataggaa cttcggaata ggaacttcaa gatcccctca 60
cgctgccgca agcactcagg gcgcaagggc tgctaaagga agcggaacac gtagaaagcc 120
agtccgcaga aacggtgctg accccggatg aatgtcagct actgggctat ctggacaagg 180
gaaaacgcaa gcgcaaagag aaagcaggta gcttgcagtg ggcttacatg gcgatagcta 240
gactgggcgg ttttatggac agcaagcgaa ccggaattgc cagctggggc gccctctggt 300
aaggttggga agccctgcaa agtaaactgg atggctttct tgccgccaag gatctgatgg 360
cgcaggggat caagatctga tcaagagaca ggatgaggat cgtttcgcat gattgaacaa 420
gatggattgc acgcaggttc tccggccgct tgggtggaga ggctattcgg ctatgactgg 480
gcacaacaga caatcggctg ctctgatgcc gccgtgttcc ggctgtcagc gcaggggcgc 540
ccggttcttt ttgtcaagac cgacctgtcc ggtgccctga atgaactgca ggacgaggca 600
gcgcggctat cgtggctggc cacgacgggc gttccttgcg cagctgtgct cgacgttgtc 660
actgaagcgg gaagggactg gctgctattg ggcgaagtgc cggggcagga tctcctgtca 720
tctcaccttg ctcctgccga gaaagtatcc atcatggctg atgcaatgcg gcggctgcat 780
acgcttgatc cggctacctg cccattcgac caccaagcga aacatcgcat cgagcgagca 840
cgtactcgga tggaagccgg tcttgtcgat caggatgatc tggacgaaga gcatcagggg 900
ctcgcgccag ccgaactgtt cgccaggctc aaggcgcgca tgcccgacgg cgaggatctc 960
gtcgtgaccc atggcgatgc ctgcttgccg aatatcatgg tggaaaatgg ccgcttttct 1020
ggattcatcg actgtggccg gctgggtgtg gcggaccgct atcaggacat agcgttggct 1080
acccgtgata ttgctgaaga gcttggcggc gaatgggctg accgcttcct cgtgctttac 1140
ggtatcgccg ctcccgattc gcagcgcatc gccttctatc gccttcttga cgagttcttc 1200
tgagcgggac tctggggttc gaaatgaccg accaagcgac gcccaacctg ccatcacgag 1260
atttcgattc caccgccgcc ttctatgaaa ggttgggctt cggaatcgtt ttccgggacg 1320
ccggctggat gatcctccag cgcggggatc tcatgctgga gttcttcgcc caccccagct 1380
tcaaaagcgc tctgaagttc ctatactttc tagagaatag gaacttc 3267
<210> 3
<211>480
<212> DNA
<213> Escherichia coli BL21(DE3)
<221> 二氢叶酸还原酶基因(folA)的核苷酸序列
<222>(1)…(480)
<400> 3
atgatcagtc tgattgcggc gttagcggta gatcgcgtta tcggcatgga aaacgccatg 60
ccgtggaacc tgcctgccga tctcgcctgg tttaaacgca acaccttaaa taaacccgtg 120
attatgggcc gccatacctg ggaatcaatc ggtcgtccgt tgccaggacg caaaaatatt 180
atcctcagca gtcaaccggg tacggacgat cgcgtaacgt gggtgaagtc ggtggatgaa 240
gccatcgcgg cgtgtggtga cgtaccagaa atcatggtga ttggcggcgg tcgcgtttat 300
gaacagttct tgccaaaagc gcaaaaactg tatctgacgc atatcgacgc agaagtggaa 360
ggcgacaccc atttcccgga ttacgagccg gatgactggg aatcggtatt cagcgaattc 420
cacgatgctg atgcgcagaa ctctcacagc tattgctttg agattctgga gcggcggtaa 480
<210> 4
<211>891
<212> DNA
<213> Escherichia coli BL21(DE3)
<221> 亚甲基四氢叶酸还原酶基因(metF)的核苷酸序列
<222>(1)…(891)
<400> 4
atgagctttt ttcacgccag ccagcgggat gccctgaatc agagcctggc agaagtccag 60
gggcagatta acgtttcgtt cgagtttttc ccgccgcgta ccagtgaaat ggagcagacc 120
ctgtggaact ccatcgatcg ccttagcagc ctgaaaccga agtttgtatc ggtgacctat 180
ggcgcgaact ccggcgagcg cgaccgtacg cacagcatta ttaaaggcat taaagatcgc 240
actggtctgg aagcggcacc gcatcttact tgcattgatg cgacgcccga cgagctgcgc 300
accattgcac gcgactactg gaataacggt attcgtcata tcgtggcgct gcgtggcgat 360
ctgccgccgg gaagtggtaa gccagaaatg tatgcttctg acctggtgac gctgttaaaa 420
gaagtggcag atttcgatat ctccgtggcg gcgtatccgg aagttcaccc ggaagcaaaa 480
agcgctcagg cggatttgct taatctgaaa cgcaaagtgg atgccggagc caaccgcgcg 540
attactcagt tcttcttcga tgtcgaaagc tacctgcgtt ttcgtgaccg ctgtgtatcg 600
gcgggcattg atgtggaaat tattccggga attttgccgg tatctaactt taaacaggcg 660
aagaaatttg ccgatatgac caacgtgcgt attccggcgt ggatggcgca aatgttcgac 720
ggtctggatg atgatgccga aacccgcaaa ctggttggcg cgaatattgc catggatatg 780
gtgaagattt taagccgtga aggagtgaaa gatttccact tctatacgct taaccgtgct 840
gaaatgagtt acgcgatttg ccatacgctg ggggttcgac ctggtttata a 891
<210> 5
<211>3288
<212> DNA
<213> Clostridium autoethanogenum
<221> 亚甲基四氢叶酸脱氢酶、甲酰四氢叶酸环水解酶、甲酸四氢叶酸连接酶基因(fhs-fchA-folD)的核苷酸序列
<222>(1)…(3288)
<400> 5
atgacttata aatcagacat cgaaatagct caagaatgca caatgaagga cattaaggaa 60
attgcaaaga aattaaatat ttccgaagat gatattgaat tgtatggtaa atacaaagca 120
aaggtaaatt acaacttgtt aaagactaca cctggtaaga atggaaaact tatattatgt 180
acagctataa acccaacacc tgctggagaa ggaaaaacta ctacagcaat aggtgtagca 240
gatgcattaa atagaatggg aaaatctgtt gttgttgcac ttagagaacc atctatggga 300
cctgtatttg gtataaaagg tggagctgcc ggcggtggat atgctcaagt agtacctatg 360
gaagacataa acctacactt tacaggtgat atacatgcac tcactgctgc taacaattta 420
cttgcagcaa tgatagataa tcatatatat caaggcaata aacttaacat agacccaaga 480
aggattgctt ggagaagatg cgtagacatg aacgacagac agctcaggtt tgtagttgat 540
ggattaggtg gaaaagccaa tggtacacct agagaagatg gatttgatat aacagttgct 600
tcagaaataa tggctatatt ctgtttatca agtgacataa ttgatttaaa gaacagaatt 660
gctaaaatag ttgtaggata tactagagat ggcaagcctg taacagctca tgatttaaaa 720
gctgaaggag ctatggcagc acttcttaaa gatgcattaa aaccaaatct agttcaaact 780
cttgaaggaa caccagcatt tgtacacggc ggaccatttg caaatatagc tcatggttgt 840
aactcaataa tggctactag aatggctctt cactttggtg attatgtagt tacggaggca 900
ggtttcggtg ctgacctagg tgctgaaaaa ttcttagata tcaagtgcag aatggcagga 960
ttaaaaccag atgcagtaat aatagttgct acagttagag cattgaaata caacggcgga 1020
gttccaaagg ctgacttaaa taatgaaaac ttagaagctc ttgaaaaagg acttccaaat 1080
ttattaaaac atgtagagaa tataaccaag gtatacaaat taccagcagt agttgcatta 1140
aatgcattcc ctacagatac gcaggcagaa ttaaaattag tagaagataa atgtaaagaa 1200
ttaggcgtaa atgtaagatt atcagaagtt tgggctaaag gcggcgaagg tggaatagaa 1260
gttgccaaag aagtgcttag acttataaaa gaagagaaaa atgacttcca gtttgcttat 1320
gatgaaaaat taccaatcag agataaaata agagcagtag ctcaaaagat atatggtgct 1380
gatgatgtta ctttcacaaa tcaggcagac aaagaaattg atgagcttga aaaattagga 1440
tttggtaaaa caccagtatg tatagcaaag actcaatact ccttaactga tgaccagact 1500
aaacttggaa gaccaacagg atttaatatt acagtaagac aggttacaat ttctgctgga 1560
gcaggttttg tagttgcagt aactggttca ataatgaaga tgccaggcct tggaaaagtt 1620
ccatctgctg aaaaaataga tgtagatgaa aatggagtaa taagcggatt attctaaaaa 1680
catttaggag gaaacaatat gaaattagca gataaaagtt gcacagattt tatagaagtt 1740
cttgcatcta aagctgcaac tcctggtgga ggcggaggat cagctattac aggtgctata 1800
ggaatggcac ttggaggcat ggtatgtaac cttacaatag gaaagaaaaa gtatgcacag 1860
tatgacgaaa aggtaaaagg catacttaaa agatctgatg agcttcaagc agagctttta 1920
aagatgatgg atgcagatgc agagtgtttt ctacctcttt caaaggctta tggaatgcca 1980
aaagacactg aagagcagaa aaaaataaaa gaagaaactc tagaaaagtg tctaaaacaa 2040
gcatgcagtg ttccagtaag cattgttaag caagcttatg aagcaataaa actccatgag 2100
gcacttgtag ataactgttc caaacttgca ataagtgatg ttggtgtagg agttcagtgt 2160
ctaagagctg ctattattgg agcacagctt aatgtcataa tcaacataaa ttctattaaa 2220
gatcaggaat atgttaaaaa ggtaaaagcg gagacggaac ctttagttga agaaggcatt 2280
aagattgcag ataaggtata tgaaaaagta gttagtgcac tttccaaata aaattattat 2340
tctccagaag aaattttaat ttcttctgga ggcacttgta aattagttta gtatggtaca 2400
gatagctaat tttaatatga aggagatata agtatgggtc aaataattaa aggtaaacca 2460
gtggcagatg ctataagtga aactttaact aaagaagtta atgatttaaa ggtaaagggt 2520
attactccaa agcttacatt agtaagagtt ggagcaaacg gaagtgacct tgcttatgaa 2580
aaaggagctc taaaaaagtg cgaaaaaatt ggaatagagg cagtcgttaa agagctacca 2640
gcagatatat cacaggacaa gtttattgaa gaattgaaaa aaataaatgc ggacaagact 2700
gtaaatgcaa taatggtatt cagaccattt cctaagcaat tagatgaaag tgttataaag 2760
tatataatcg cccctgagaa agatgtagat tgctttagtc ctgtaaatgt tgctaaattg 2820
atggaaaaag atatgacagg ttttgcacct tgtacaccat ctgcggttat agaaatcctt 2880
aagcattata aagttcctat gaagggaaaa aatgcagtta tagtaggaag atctatggta 2940
gttggaaaac cagcgtgcat gctgctctta aatgaaaatg ctacagttac cgtatgccat 3000
tcaaaaacta ctgatatgcc aaaggtttgt tcccaggcag acatactggt agtaggcata 3060
ggaaaagcta aaatgataga ttcaaaatat gtaaaagatg gtgccgtagt tatagatgta 3120
ggcataaatg tagatgaaag tggaaagtta tgtggagatg tagatacaga agactgtgaa 3180
gcaaaagctt caatgataac gccagttcct aaaggagtag gctcagttac gtcatctata 3240
cttgcacagc atattgtaaa agcatgtaag ttacaaaata acctataa 3288
<210> 6
<211>2186
<212> DNA
<213> Methylobacterium extorquens AM1
<221> 甲酸四氢叶酸连接酶基因(ftfL)的核苷酸序列
<222>(1)…(2186)
<400> 6
tcgacgtggc tcaagcgctg acccaggccg gttacaccgc caccgcgatg accggttgaa 60
accattcggc ctcgcgcgcc ggccggcggc ggatcacctg tcccaaacca cctgtcccat 120
gagaaaactt aacggtcggg ttaaaaaaaa tccgagacgc ttttcgtcgt cgtttcgctc 180
acactgccac gatcggttta tcgtggccgt tccgttcgct accacggaag catagggacg 240
gaccgggcga cggctcggca cgccgcgagc ccgcgtgaac aagaaacgac ggtgagagaa 300
atgccctcag atatcgagat cgcccgcgcg gcgaccctga agccgatcgc ccaggtcgcc 360
gaaaagctcg gcatcccgga cgaggcgctt cacaactacg gcaagcacat cgccaagatc 420
gaccacgact tcatcgcctc gctcgagggt aagcccgagg gcaagctggt gctcgtcacc 480
gcgatctcgc cgacgcccgc gggcgagggc aagaccacca cgaccgtggg tctcggcgac 540
gcactcaacc ggatcggcaa gcgggcggtg atgtgcctgc gcgagccctc gctcggcccc 600
tgcttcggca tgaagggcgg cgcggccggt ggcggcaagg cccaggtcgt gccgatggag 660
cagatcaacc tgcacttcac cggggacttc cacgccatca cctcggcgca ctcgctcgcc 720
gccgcgctga tcgacaacca catctactgg gccaacgagc tcaacatcga cgtgcgccgc 780
atccactggc gccgcgtggt cgacatgaac gaccgggcgc tgcgcgcgat caaccagtcg 840
ctcggcggcg tcgccaacgg ctttccgcgt gaggacgggt tcgacatcac cgtcgcctcc 900
gaggtgatgg cggtgttctg cctcgccaag aatctggccg acctcgagga gcggctcggc 960
cgcatcgtca tcgccgagac ccgcgaccgc aagccggtga cgctggccga cgtgaaggcg 1020
accggcgcga tgaccgttct cctcaaggat gcgctgcagc cgaacctcgt gcagacgctg 1080
gagggcaacc cggccctgat ccatggcggc ccgttcgcca acatcgccca cggctgcaac 1140
tcggtgatcg ccacccgtac cggcctgcgg ctggccgact acaccgtcac cgaggccggc 1200
ttcggcgcgg atctcggcgc ggagaagttc atcgacatca agtgccgcca gaccggcctc 1260
aagccctcgg cggtggtgat cgtcgccacg atccgcgccc tcaagatgca tggcggcgtc 1320
aacaagaagg atctccaggc tgagaacctc gacgcgctgg agaagggttt cgccaacctc 1380
gagcgccacg tgaacaacgt gcggagcttc ggcctgccgg tggtggtggg cgtgaaccac 1440
ttcttccagg acaccgacgc cgagcatgcc cggttgaagg agctctgccg cgaccgtctt 1500
caggtcgagg cgatcacctg caagcactgg gcggagggcg gcgcgggcgc cgaggctctg 1560
gcgcaggccg tggtgaagct cgccgagggc gagcagaagc cgctgacctt cgcctacgaa 1620
actgagacga agatcaccga caagatcaag gcgatcgcga ccaagctcta cggtgcggcc 1680
gatatccaga tcgagtcgaa ggccgccacc aagctcgccg gcttcgagaa ggatggctac 1740
ggcggattgc ccgtctgcat ggccaagacg cagtactcgt tctcgaccga cccgaccctg 1800
atgggcgcgc cctcgggcca cctcgtctcg gtgcgcgacg tgcgcctctc ggcgggcgcc 1860
ggcttcgtcg tggtgatctg cggtgagatc atgaccatgc cgggcctgcc caaggtgccg 1920
gcggcggaca ccatccgcct cgacgccaac ggtcagatcg acgggctgtt ctagccgctg 1980
ctctcagccc tccccctacc caagtcgggc ttgcccgact tgggcggatc gttgcggatc 2040
tcgggcaagc ccgaggtccg tcgggggagg gccctttgcc ctctgcgcta cgccgccagc 2100
ccgcgcttct tcagcagcgg ctcgatgctc ggcagccgcc cccggaacgc cgtataggcc 2160
tcgcgcgcat cgcgcaggtt gcccgc 2186
<210> 7
<211>1587
<212> DNA
<213> Methylobacterium extorquens AM1
<221> 甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因(fchA-mtdA)的核苷酸序列
<222>(1)…(1587)
<400> 7
atgtccaaga agctgctctt ccagttcgac accgatgcca cgccgagcgt cttcgacgtc 60
gtcgtcggct acgacggcgg tgccgaccac atcaccggct acggcaacgt cacgcccgac 120
aacgtcggcg cctatgtcga cggcacgatc tacacccgcg gcggcaagga gaagcagtcg 180
acggcgatct tcgtcggcgg cggcgacatg gcggccggcg agcgggtgtt cgaggcggtg 240
aagaagcgct tcttcggccc gttccgcgtg tcctgcatgc tggattcgaa cggctccaac 300
acgaccgccg cggcgggtgt ggcgctcgtc gtcaaggcgg cgggcggctc ggtcaagggc 360
aagaaggccg tcgtgctcgc gggcaccggc ccggtcggca tgcgctcggc ggcgctgctc 420
gccggcgagg gcgccgaggt cgtgctgtgc gggcgcaagc tcgacaaggc gcaggccgcg 480
gccgattccg tgaacaagcg cttcaaggtg aacgtcaccg cggccgaaac cgcggacgac 540
gcttcgcgcg ccgaggccgt gaagggcgcc catttcgtct tcaccgccgg tgcgatcggc 600
cttgaactgc tgccgcaggc agcctggcag aacgagagtt cgatcgagat cgtggccgac 660
tacaacgccc agccgccgct cggcatcggc gggatcgatg cgaccgacaa aggcaaggaa 720
tacggcggaa agcgcgcctt cggtgcgctc ggcatcggcg gcttgaagct caagctgcac 780
cgcgcctgca tcgccaagct gttcgagtcg agcgaaggcg tcttcgacgc cgaggagatc 840
tacaagctgg ccaaggaaat ggcctgacgg ctcacggccc aaagggtcac agctcaatgg 900
gcggcgccgg ccttcggcgc cgccccagcg aatcaacaag aactgacagg ggagggaccc 960
atggccggca acgagacgat cgaaacattc ctcgatggcc tggcgagctc ggccccgacc 1020
cccggcggcg gcggtgccgc cgcgatctcc ggcgccatgg gcgcggcgct ggtctcgatg 1080
gtgtgtaacc tcaccatcgg caagaagaag tatgtcgagg tcgaggccga cctgaagcag 1140
gtgctggaga agtcggaagg cctgcgccgc acgctcaccg gcatgatcgc cgacgacgtc 1200
gaggctttcg acgcggtgat gggcgcctac gggctgccga aaaacaccga cgaggagaag 1260
gctgcccgcg ccgccaagat tcaggaggcg ctcaagaccg cgaccgacgt gccgctcgcc 1320
tgctgccgcg tctgccgcga ggtgatcgat ctggccgaga tcgtcgccga gaagggcaat 1380
ctcaacgtca tctcggatgc cggcgtcgcc gtgctctcgg cctatgccgg tctgcgctcg 1440
gcggccctca acgtctacgt caacgccaag ggcctcgacg accgcgcctt cgccgaggag 1500
cggctgaagg agctggaagg cctgctggcc gaggcgggcg cgctcaacga gcggatctac 1560
gagacggtga agtccaaggt aaactga 1587
Claims (3)
1.一种生物法生产L-5-甲基四氢叶酸的方法,步骤是:
(1)构建产L-5-甲基四氢叶酸(L-5-MTHF)的工程菌:
a. 以大肠杆菌E. coli BL21(DE3)基因组为模板扩增SEQ ID NO.3所示的二氢叶酸还原酶基因folA以及SEQ ID NO.4所示的亚甲基四氢叶酸还原酶基因metF,将folA基因和metF基因克隆到pACYCDuet-1载体的两个多克隆位点上,构建重组质粒,命名为pACYCDuet-metF-folA;以自产乙醇梭菌(C. autoethanogenum)基因组为模板扩增SEQ ID NO.5所示的甲酸四氢叶酸连接酶、甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因fhs-fchA-folD,将fhs-fchA-folD基因克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-WL;以扭脱甲基杆菌(M. extorquens)AM1基因组作为模板扩增SEQ ID NO.6所示的甲酸四氢叶酸连接酶基因ftfL以及SEQ ID NO.7所示的甲酰四氢叶酸环水解酶和亚甲基四氢叶酸脱氢酶基因fchA-mtdA,将ftfL、fchA和mtdA克隆到pETDuet-1载体的多克隆位点上,构建重组载体,命名为pETDuet-C1T;
b. 将质粒pACYCDuet-metF-folA和pETDuet-WL共同转化到E. coli BL21(DE3)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养,阳性菌落菌株即为产L-5-MTHF的工程菌,命名为BL21-WL;将质粒pACYCDuet-metF-folA和pETDuet-C1T共同转化到敲除甲硫氨酸合成酶基因(metH)的E. coli BL21(ΔmetH)感受态细胞中,在含氯霉素和氨苄青霉素抗性的LB固体平板上培养,阳性菌落菌株即为产L-5-MTHF的工程菌,命名为BL21(ΔmetH)-C1T;
(2)产L-5-MTHF的工程菌发酵:
将产L-5-MTHF的工程菌BL21-WL菌株或BL21(ΔmetH)-C1T菌株以体积比1~5%的接种量接种到含有氨苄青霉素和氯霉素的发酵培养基中,在37±1℃和180~220 rpm转速条件下培养2~4小时至OD600nm为0.6~1.0,获得菌液;向制得的菌液中加入终浓度为0.4~0.8 mM 的IPTG,在20~37℃、100~120 rpm转速下诱导8~16小时,然后将培养液离心收集菌体,即获得含L-5-MTHF的工程菌细胞;
其中,上述发酵培养基的配方及组分终浓度是:胰蛋白胨 10~15 g∙L-1,酵母粉 20~30g∙L-1,甘油 2~5 ml∙L-1,叶酸 0.01~0.4 g∙L-1,甲酸钠 0.1~4.0 g∙L-1,KH2PO4 2~4 g∙L-1,K2HPO4 12~14 g∙L-1;氨苄青霉素终浓度为50 µg∙ml-1,氯霉素的终浓度为25 μg∙ml-1;
(3)破碎工程菌细胞,释放出L-5-MTHF:
将离心后获得的工程菌细胞在厌氧箱中用含0.1%的抗坏血酸和含0.1%巯基乙醇的50mM pH 7.2 的经煮沸后脱气厌氧处理的Tris-HCl溶液重悬,密封在厌氧小瓶中,100℃水浴煮沸10 min破碎细胞,即得含L-5-MTHF的细胞破碎液,立即将其冰浴,并于15,000 rpm,4℃离心15 min后收集上清,再加入新鲜小鼠血清至100 µl∙ml-1,37℃反应3 h,煮沸5 min终止反应,离心取上清,用0.22 µm的醋酸纤维素滤膜过滤,滤液装入液相小瓶;
(4)使用201×7强碱性苯乙烯系阴离子交换树脂纯化L-5-MTHF,并使用高效液相色谱(HPLC)对L-5-MTHF产量进行测定:
其中L-5-MTHF的纯化方法是:用1 M的NaOH和1 M的HCl处理强碱性苯乙烯系阴离子交换树脂2次,超纯水洗至中性,再用1 M的NaOH浸泡树脂24 h,将其转变为OH型,用超纯水洗至中性,用50 mM pH 7.2的Tris-HCl缓冲液平衡柱子至流出液与缓冲液pH值相同,将步骤(3)液相小瓶中的滤液样品在避光条件下上样,用0.1 M pH 7.2的NaCl洗脱,紫外检测器在290 nm下检测并收集洗脱液;
其中HPLC对L-5-MTHF测定的方法是:荧光检测器Ex=290 nm, Em=356 nm,以体积比为93:7的33 mM pH 3.0磷酸钾和乙腈为流动相,上样量20 µl,走样时间30 min,柱温箱温度为30℃,保留时间为19.3±0.1min。
2.根据权利要求1所述生物法生产L-5-MTHF的方法,其特征在于:步骤(2)所述工程菌BL21-WL菌株或BL21(ΔmetH)-C1T菌株的发酵条件是在37℃和200 rpm转速条件下培养2~3小时至OD600nm为0.6~0.8,并向菌液中加入终浓度为0.6~0.8 mM 的IPTG,在20~25℃、100~110 rpm转速下诱导12~16小时。
3.根据权利要求1所述生物法生产L-5-MTHF的方法,其特征在于:步骤(2)所述发酵培养基的配方及组分终浓度是:胰蛋白胨 12 g∙L-1,酵母粉 24 g∙L-1,甘油 4 ml∙L-1,叶酸0.13 g∙L-1,甲酸钠 1.3 g∙L-1,KH2PO4 2.3g∙L-1,K2HPO4 12.5 g∙L-1。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110672088.1A CN113403355B (zh) | 2021-06-17 | 2021-06-17 | 一种生物法生产l-5-甲基四氢叶酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110672088.1A CN113403355B (zh) | 2021-06-17 | 2021-06-17 | 一种生物法生产l-5-甲基四氢叶酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113403355A CN113403355A (zh) | 2021-09-17 |
CN113403355B true CN113403355B (zh) | 2022-05-31 |
Family
ID=77684672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110672088.1A Active CN113403355B (zh) | 2021-06-17 | 2021-06-17 | 一种生物法生产l-5-甲基四氢叶酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113403355B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114015620B (zh) * | 2021-12-13 | 2023-02-03 | 青岛农业大学 | 一株高效利用甲酸的扭脱甲基杆菌进化菌及其应用 |
CN115873814B (zh) * | 2022-09-16 | 2025-03-04 | 宁夏伊品生物科技股份有限公司 | 双功能亚甲基四氢叶酸脱氢酶编码基因folD在L-氨基酸合成中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102776217A (zh) * | 2012-07-16 | 2012-11-14 | 中国药科大学 | 一种提高l-5-甲基四氢叶酸累积量的生物合成方法 |
WO2014146975A1 (en) * | 2013-03-22 | 2014-09-25 | Chemo Research, S.L. | FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca) |
CN105861534A (zh) * | 2016-05-12 | 2016-08-17 | 中国药科大学 | 一种双质粒工程菌提高l-5-甲基四氢叶酸产量的生物方法 |
CN109536430A (zh) * | 2018-12-18 | 2019-03-29 | 江南大学 | 一种积累l-5-甲基四氢叶酸乳酸乳球菌及其构建方法 |
CN111172091A (zh) * | 2020-02-17 | 2020-05-19 | 江南大学 | 一种5-甲基四氢叶酸产量提高的枯草芽孢杆菌及其应用 |
-
2021
- 2021-06-17 CN CN202110672088.1A patent/CN113403355B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102776217A (zh) * | 2012-07-16 | 2012-11-14 | 中国药科大学 | 一种提高l-5-甲基四氢叶酸累积量的生物合成方法 |
WO2014146975A1 (en) * | 2013-03-22 | 2014-09-25 | Chemo Research, S.L. | FORMULATION OF AMORPHOUS CALCIUM L-5-METHYLTETRAHYDROFOLATE (L-5-MTHF-Ca) |
CN105861534A (zh) * | 2016-05-12 | 2016-08-17 | 中国药科大学 | 一种双质粒工程菌提高l-5-甲基四氢叶酸产量的生物方法 |
CN109536430A (zh) * | 2018-12-18 | 2019-03-29 | 江南大学 | 一种积累l-5-甲基四氢叶酸乳酸乳球菌及其构建方法 |
CN111172091A (zh) * | 2020-02-17 | 2020-05-19 | 江南大学 | 一种5-甲基四氢叶酸产量提高的枯草芽孢杆菌及其应用 |
Non-Patent Citations (2)
Title |
---|
Engineering of Biosynthesis Pathway and NADPH Supply for Improved L-5-Methyltetrahydrofolate Production by Lactococcus lactis;Chuanchuan Lu et al.;《JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY》;20210131;第31卷(第1期);第154-162页 * |
Systems metabolic engineering of Bacillus subtilis for efficient biosynthesis of 5-methyltetrahydrofolate;Han Yang et al.;《Biotechnology and Bioengineering》;20200731;第117卷(第7期);第2116-2130页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113403355A (zh) | 2021-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021501595A (ja) | 遺伝子改変バチルス・サブティリス(Bacillus subtilis)株、最適化されたベクター、及びその使用 | |
CN111019878B (zh) | L-苏氨酸产量提高的重组大肠杆菌及其构建方法与应用 | |
CN113403355B (zh) | 一种生物法生产l-5-甲基四氢叶酸的方法 | |
CN115992189B (zh) | 一种细菌色氨酸-5-羟化酶及其应用 | |
CN108913643A (zh) | 一种提高分枝杆菌辅酶再生同时促进雄烯二酮生产的方法 | |
WO2022174597A1 (zh) | 一种用于l-肌氨酸生产的基因工程菌及构建方法与应用 | |
CN106399216B (zh) | 一种高效合成α-氨基丁酸的单细胞工厂及其构建与应用 | |
CN111394288B (zh) | 重组谷氨酸棒杆菌、其构建方法及其生产四氢嘧啶的方法 | |
CN115595314A (zh) | 表达天冬氨酸脱氢酶的工程菌及发酵生产维生素b5的方法 | |
CN116970622A (zh) | 稳定遗传筛选元件及其构建方法和应用 | |
CN108865905A (zh) | 一种产不饱和脂肪酸能力提升的重组高山被孢霉工程菌 | |
CN115197954A (zh) | 用于发酵生产1,5-戊二胺的重组dna、菌株及其用途 | |
CN107354179B (zh) | 一种制备含有羟基的手性化合物的方法 | |
CN105861339B (zh) | 一株过表达gtp 环式水解酶基因的重组高山被孢霉、其构建方法及应用 | |
CN115747240A (zh) | 一种生产雌马酚的重组大肠杆菌工程菌株及应用 | |
CN114990043A (zh) | 代谢赖氨酸的工程菌及其构建方法与应用 | |
CN114990045A (zh) | 一种重组大肠杆菌及其构建方法与合成1,5-戊二胺的方法 | |
WO2020057397A1 (zh) | 一种用于重组蛋白质表达的启动子 | |
CN108148853B (zh) | 一种基因组编辑载体、其组成的基因组编辑系统及应用 | |
CN113862205B (zh) | 产羟基四氢嘧啶的嗜甲烷工程菌 | |
CN112410274B (zh) | 一种生产子囊霉素的基因工程菌及其制备方法和用途 | |
CN101892228A (zh) | 一种高丙烯酰胺和丙烯腈耐受性产腈水合酶工程菌及应用 | |
CN116286910A (zh) | 一种用于马来酸一锅生物合成l-天冬氨酸的重组基因、重组酶及其应用 | |
CN119614528A (zh) | 羟基类固醇脱氢酶突变体及在制备甾体类药物中的应用 | |
CN115851691A (zh) | 一种天冬氨酸氨裂解酶突变体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |